Crescent Biopharma, Inc. CBIO
NASDAQ · United States · Health Technology
$14.32+0.06 (+0.42%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | -0.74 | -0.74 | -0.6% | $0 | -100.0% | -2.0%$14.77→$14.47 |
| Q1 2026 | 2026-04-29 | -0.70 | -0.85 | +17.6% | — | — | -6.6%$23.96→$22.37 |
| Q4 2025 | 2026-02-26 | -4.01 | -2.22 | -80.6% | — | — | -3.2%$12.49→$12.09 |
| Q3 2025 | 2025-11-06 | -1.27 | -1.01 | -25.7% | — | — | +5.6%$12.43→$13.13 |
| Q1 2025 | 2025-06-18 | -18.39 | -3.64 | -405.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.